Researchers identify novel molecular target for pancreatic cancer

Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise

When Robert Mayer was only a few years out of residency, in the 1970s, he signed on as an investigator of the NCI-supported Gastrointestinal Tumor Study Group, which conducted research into colorectal, gastric, and pancreatic cancers.

City of Hope breaks ground for a facility uniting cancer diagnosis and treatment

City of Hope broke ground for a new Pathology and Radiation Oncology Building at its Duarte campus.

June 26, 2026

Vol.52 No.25

In Brief

MD Anderson’s Vincent Bernard receives Project Purple’s Research Recovery Grant for pancreatic cancer research

Project Purple has awarded a $375,000 Research Recovery Grant to researchers at the University of Texas MD Anderson Cancer Center to continue critical pancreatic cancer research.

June 26, 2026

Vol.52 No.25

Clinical Roundup

TAMP procedure shows 52% reduction in pancreatic tumor metabolic activity, Moffitt case study shows

Researchers at Moffitt Cancer Center have published a case study highlighting the potential optimization of the TAMP, or trans-arterial micro-perfusion, procedure with RenovoCath to deliver intra-arterial gemcitabine (a commonly used chemotherapy) directly near a tumor (rather than traditional systemic IV administration) in a patient with locally advanced pancreatic cancer.

June 26, 2026

Vol.52 No.25

Clinical Roundup

Sylvester researchers discover method of disrupting inflammatory network that helps pancreatic cancer resist treatment

Blocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven inflammatory network that helps pancreatic cancer resist treatment, according to a study led by researchers at Sylvester Comprehensive Cancer Center.

June 26, 2026

Vol.52 No.25

Survivorship begins at diagnosis—cancer care system must recognize this

The oncology field is confronting three forces simultaneously.

June 12, 2026

Vol.52 No.23

By Saro Armenian

Researchers identify novel molecular target for pancreatic cancer

YOU MAY BE INTERESTED IN

Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise

City of Hope breaks ground for a facility uniting cancer diagnosis and treatment

MD Anderson’s Vincent Bernard receives Project Purple’s Research Recovery Grant for pancreatic cancer research

TAMP procedure shows 52% reduction in pancreatic tumor metabolic activity, Moffitt case study shows

Sylvester researchers discover method of disrupting inflammatory network that helps pancreatic cancer resist treatment

Survivorship begins at diagnosis—cancer care system must recognize this

Renew today!

Subscriber content

Never miss an issue!

Login